Sun BioPharma, Inc. Note Agreements
8 Contracts & Agreements
- Senior Convertible Promissory Tranche A Note issued to Nant Capital, LLC, dated October 22, 2024 (Filed With SEC on October 28, 2024)
- Note Purchase Agreement, dated October 22, 2024, between Nant Capital, LLC, as Investor, and Panbela Therapeutics, Inc., as Company (Filed With SEC on October 28, 2024)
- Subordinated Promissory Note, dated as of August 8, 2024 (Filed With SEC on August 13, 2024)
- Term Promissory Note issued to USWM, LLC, dated July 24, 2024 (Filed With SEC on July 30, 2024)
- Form of Convertible Promissory Note (Filed With SEC on December 28, 2018)
- SUN BIOPHARMA, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on March 6, 2017)
- NOTE PURCHASE AGREEMENT (Filed With SEC on March 6, 2017)
- SUN BIOPHARMA, INC. CONVERTIBLE PROMISSORY NOTE (Filed With SEC on September 11, 2015)
